— Health news and commentary gathered by MedPage Today staff
May 21, 2026
• 2 min read
Note that some links may require registration or subscription.
U.S. officials are working with Mapp Biopharmaceutical, a small biotech company based in San Diego, to provide an experimental monoclonal antibody treatment for Ebola as the epidemic worsens. (Bloomberg via MSN)












